Karen S. Schlumpf
Westat
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Karen S. Schlumpf.
Transfusion | 2006
George B. Schreiber; Karen S. Schlumpf; Simone A. Glynn; David Wright; Yongling Tu; Melissa King; Martha J. Higgins; Debra Kessler; Ronald O. Gilcher; Catharie C. Nass; Anne M. Guiltinan
BACKGROUND: To prevent donor loss and improve retention, it is important to understand the major deterrents to blood donation and to identify factors that can be effectively addressed by blood centers.
Transfusion | 2007
Whitney R. Steele; George B. Schreiber; Anne M. Guiltinan; Catharie C. Nass; Simone A. Glynn; David Wright; Debra Kessler; Karen S. Schlumpf; Yongling Tu; James W. Smith; George Garratty
BACKGROUND: Blood donation can be described as a prosocial behavior, and donors often cite prosocial reasons such as altruism, empathy, or social responsibility for their willingness to donate. Previous studies have not quantitatively evaluated these characteristics in donors or examined how they relate to donation frequency.
Transfusion | 2007
Karen S. Schlumpf; Simone A. Glynn; George B. Schreiber; David Wright; Whitney R. Steele; Yongling Tu; Sigurd Hermansen; Martha J. Higgins; George Garratty; Edward L. Murphy
BACKGROUND: To predict future blood donation behavior and improve donor retention, it is important to understand the determinants of donor return.
Transfusion | 2010
Alan E. Mast; Karen S. Schlumpf; David Wright; Brian Custer; Bryan Spencer; Edward L. Murphy; Toby L. Simon
BACKGROUND: Approximately 10% of attempted blood donations are not allowed because of low hemoglobin (Hb) deferral.
Blood | 2009
Steven H. Kleinman; Simone A. Glynn; Tzong-Hae Lee; Leslie H. Tobler; Karen S. Schlumpf; Deborah Todd; Hannah Qiao; Mei-ying W. Yu; Michael P. Busch
Parvovirus B19V infection can be a serious infection for hematology patients with underlying hemolysis or compromised erythropoiesis syndromes. Although case reports of B19V transmission by blood component transfusion (as contrasted to manufactured plasma derivatives) are rare, no studies have systematically determined a rate of transmission to recipients transfused with B19V DNA-positive components. We used a linked donor and recipient repository and a sensitive, quantitative B19V DNA polymerase chain reaction (PCR) assay to assess such transmission in B19V-susceptible (ie, anti-B19V immunoglobulin G [IgG] negative) recipients. We assessed 112 B19V DNA-positive components from 105 donors (of 12 529 tested donations) transfused into a population of surgical patients with a pretransfusion B19V IgG seroprevalence of 78%. We found no transmission to 24 susceptible recipients from transfusion of components with B19V DNA at concentrations less than 10(6) IU/mL (upper 95% confidence interval, 11.7%). We found an anamnestic IgG response in one pretransfusion seropositive recipient transfused with a component containing greater than 10(10) IU/mL B19V DNA. These findings show either that transmission from components with less than 10(6) IU/mL does not occur, or, if it does, it is an uncommon event. These data do not support the need to routinely screen blood donations with a sensitive B19V DNA nucleic acid assay.
Transfusion | 2011
Brian Custer; Karen S. Schlumpf; David Wright; Toby L. Simon; Susan L. Wilkinson; Paul M. Ness
BACKGROUND: The consequences of temporary predonation deferral are unsatisfactorily understood. Studies have found that deferral negatively impacts future donor return. However, the applicability of these findings across centers has not been established.
Transfusion | 2012
Brian Custer; Jorge A. Rios; Karen S. Schlumpf; Ram Kakaiya; Jerome L. Gottschall; David Wright
BACKGROUND: The importance of adverse reactions in terms of donor safety recently has received significant attention, but their role in subsequent donation behavior has not been thoroughly investigated.
Transfusion | 2012
Brian Custer; Karen S. Schlumpf; Toby L. Simon; Bryan Spencer; David Wright; Susan L. Wilkinson
BACKGROUND: Descriptions of donor demographics are of value in formulating recruitment and retention strategies. The demographics of successful (SV), unsuccessful (UV; meaning a nonuseable unit), and deferred (DV) donor visits over a 4‐year period were investigated using Retrovirus Epidemiology Donor Study (REDS)‐II databases.
Transfusion | 2010
Erik Scott; Karen S. Schlumpf; Sunitha Mathew; Alan E. Mast; Michael P. Busch; Jerome L. Gottschall
BACKGROUND: Sponsored by the National Heart, Lung, and Blood Institute, the Retrovirus Epidemiology Donor Studies (REDS‐I/‐II) have conducted epidemiologic, laboratory, and survey research on volunteer blood donors. Some studies request additional permission to store biospecimens for future studies. The representativeness and applicability of studies performed using repositories may be reduced by low participation rates.
Transfusion | 2012
Thelma T. Gonçalez; Ester C. Sabino; Karen S. Schlumpf; David Wright; Silvana Leão; Divaldo Sampaio; Pedro Losco Takecian; Anna B. Proitetti; Edward L. Murphy; Michael P. Busch; Brian Custer
BACKGROUND: In Brazil little is known about adverse reactions during donation and the donor characteristics that may be associated with such events. Donors are offered snacks and fluids before donating and are required to consume a light meal after donation. For these reasons the frequency of reactions may be different than those observed in other countries.